Conolidine’s analgesic outcomes stem from its conversation with non-opioid pain pathways. Not like opioids, which bind to µ-opioid receptors during the central nervous process, conolidine modulates alternate molecular targets. A Science Improvements examine uncovered that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, whi… Read More